News headlines about Allscripts Healthcare Solutions (NASDAQ:MDRX) have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned media headlines about the software maker an impact score of 46.535692645387 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s rankings:
- Allscripts Healthcare Solutions, Inc. (MDRX) Receives Buy Rating from SunTrust Banks, Inc. (americanbankingnews.com)
- Allscripts Healthcare Solutions (MDRX) Q3 2017 Results – Earnings Call Transcript (seekingalpha.com)
- Allscripts Healthcare Solutions, Inc. to Host Earnings Call (finance.yahoo.com)
- Allscripts announces third quarter 2017 results (finance.yahoo.com)
- AllScripts reports 3Q loss (finance.yahoo.com)
A number of analysts have weighed in on the stock. Cantor Fitzgerald raised shares of Allscripts Healthcare Solutions from a “neutral” rating to an “overweight” rating and set a $12.00 target price on the stock in a report on Tuesday, August 15th. Robert W. Baird increased their price objective on shares of Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday. KeyCorp reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Friday, October 27th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday. Finally, Dougherty & Co reaffirmed a “buy” rating and issued a $16.00 price objective (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a report on Tuesday, October 3rd. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have assigned a buy rating to the stock. Allscripts Healthcare Solutions presently has an average rating of “Hold” and a consensus target price of $15.13.
Shares of Allscripts Healthcare Solutions (MDRX) traded up $0.20 on Friday, reaching $12.94. 3,153,506 shares of the company were exchanged, compared to its average volume of 1,746,091. The company has a current ratio of 0.93, a quick ratio of 0.93 and a debt-to-equity ratio of 1.13. The stock has a market cap of $2.30 billion, a P/E ratio of 29.65, a price-to-earnings-growth ratio of 2.39 and a beta of 1.35.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.04). The company had revenue of $426.10 million during the quarter, compared to analysts’ expectations of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 6.44% and a negative net margin of 12.23%. The business’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.14 EPS. equities analysts forecast that Allscripts Healthcare Solutions will post 0.45 EPS for the current year.
In other Allscripts Healthcare Solutions news, EVP Brian Farley sold 5,000 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $67,600.00. Following the sale, the executive vice president now directly owns 196,607 shares in the company, valued at approximately $2,658,126.64. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $13.56, for a total value of $203,400.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,000 shares of company stock worth $473,800. Company insiders own 0.75% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.com-unik.info/2017/11/04/allscripts-healthcare-solutions-mdrx-receiving-somewhat-positive-press-coverage-analysis-finds.html.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
What are top analysts saying about Allscripts Healthcare Solutions Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Allscripts Healthcare Solutions Inc. and related companies.